With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) offers investors broad diversification guided by experienced and savvy management.
Marijuana Industry
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis
InMed Pharmaceuticals, Inc. has broken new ground with an innovative, proprietary biosynthesis process that reliably creates pure cannabinoids.
Medical Cannabis Payment Solutions (REFG) Offers Cannabis Retailers Merchant Processing They Can Bank On
Through its wholly owned subsidiary, StateSourced, the company provides a proprietary, closed loop system of merchant processing for marijuana enterprises.
Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Why Medical Cannabis Payment Solutions (REFG) is “One to Watch”
Medical Cannabis Payment Solutions is intent on opening the bottleneck with its proprietary merchant processing system designed to serve the monetary demands of the state-legalized cannabis market.
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.
Outsized Demand in Canada’s Cannabis Market Triggers Upswing in Smart Money Flowing North
For 17 years Canada has provided legal access to medical cannabis to its citizens, and now the country is expected to legalize recreational marijuana by July 2018.
Merger and Acquisition Activity is Heating Up in the Cannabis Industry
Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Wins in Vegas!
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) had a full team at its exhibit, which attracted a lot of attention.
Cannabis Demand in Canada Creates Considerable Opportunity for ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)
As Canada prepares for the legalization of recreational marijuana in July 2018, analysts are noting a shortage of supplies compared to expected demand for cannabis products.
Investors Could Reap Global Rewards of Research into Medical Cannabis Science
Cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses.
Skinvisible, Inc.’s (SKVI) Topical Drug Delivery System Set to Enjoy New Licensing Opportunities
Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years.
Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC.